We are live on ! Find out more
3C

325 Capital Portfolio holdings

AUM $419M
1-Year Est. Return 75.74%
This Fund
S&P 500
This Quarter Est. Return
-12.07%
1 Year Est. Return
+75.74%
3 Year Est. Return
+225.71%
5 Year Est. Return
10 Year Est. Return
AUM
$285M
AUM Growth
-$43.7M
Cap. Flow
-$4.65M
Cap. Flow %
-1.63%
Top 10 Hldgs %
94.58%
Holding
13
New
1
Increased
4
Reduced
2
Closed

Top Buys

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$22.5M
2
ASTH icon
Astrana Health
ASTH
+$17.1M
3
MSAI icon
MultiSensor AI
MSAI
+$12.5M
4
DBD icon
Diebold Nixdorf
DBD
+$12.1M
5
AIOT
PowerFleet Inc
AIOT
+$978K

Top Sells

Rank Stock Value
1
ATRO icon
Astronics
ATRO
+$64.9M
2
BLBD icon
Blue Bird Corp
BLBD
+$4.88M

Sector Composition

Rank Sector Weight
1 Healthcare 26.33%
2 Consumer Staples 20.24%
3 Industrials 17.45%
4 Technology 15.84%
5 Communication Services 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEI icon
1
American Public Education
APEI
$833M
$57.8M 20.24%
1,528,503
ASTH icon
2
Astrana Health
ASTH
$1.87B
$45.6M 15.99%
1,839,076
+645,123
+54% +$17.1M
MGNI icon
3
Magnite
MGNI
$3.39B
$32.5M 11.4%
2,005,387
+1,355,326
+208% +$22.5M
BLBD icon
4
Blue Bird Corp
BLBD
$2.01B
$32M 11.2%
679,826
-93,367
-12% -$4.88M
MPAA icon
5
Motorcar Parts of America
MPAA
$227M
$24.9M 8.73%
2,018,795
AIOT
6
PowerFleet Inc
AIOT
$403M
$20.4M 7.15%
3,837,410
+191,031
+5% +$978K
LFCR icon
7
Lifecore Biomedical
LFCR
$162M
$17.7M 6.2%
2,162,466
SPIR icon
8
Spire Global
SPIR
$494M
$14.1M 4.93%
1,875,000
DBD icon
9
Diebold Nixdorf
DBD
$2.31B
$13.1M 4.6%
+193,401
New +$12.1M
BTMD icon
10
Biote Corp
BTMD
$42.4M
$11.8M 4.14%
4,548,127
MSAI icon
11
MultiSensor AI
MSAI
$10.7M
$7.63M 2.67%
662,248
+427,873
+183% +$12.5M
TACT icon
12
Transact Technologies
TACT
$53M
$4.05M 1.42%
1,011,789
ATRO icon
13
Astronics
ATRO
$3.25B
$3.8M 1.33%
84,000
-1,548,810
-95% -$64.9M

Similar funds

325 Capital's Q4 2025 Portfolio in Review

As of Q4 2025, 325 Capital held 13 positions worth $285M, down 13% from $329M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

325 Capital's Q4 2025 filing shows 1 new, 4 increased and 2 reduced positions. Its largest new stake was Diebold Nixdorf: 193,401 shares worth $13.1M. The largest sale was Astronics, an estimated $64.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Industrials.

  • 325 Capital's largest Q4 2025 buy was Diebold Nixdorf: 193,401 shares worth $13.1M.
  • 325 Capital added most to Magnite in Q4 2025, an estimated $22.5M increase.
  • 325 Capital's biggest Q4 2025 reduction was Astronics, cutting an estimated $64.9M.
  • 325 Capital's ten largest holdings make up 95% of its $285M portfolio in Q4 2025.
  • 325 Capital opened 1 new position and closed 0 in Q4 2025.
  • 325 Capital's portfolio value fell 13% quarter-over-quarter to $285M.

Based on 325 Capital's 13F filing for Q4 2025, filed 17 Feb 2026.